Zealand Pharma As Stock Market Value
| ZLDPF Stock | USD 104.20 1.45 1.41% |
| Symbol | Zealand |
Zealand Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zealand Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zealand Pharma.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Zealand Pharma on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Zealand Pharma AS or generate 0.0% return on investment in Zealand Pharma over 30 days. Zealand Pharma is related to or competes with NewAmsterdam Pharma, Portage Biotech, DBV Technologies, NewAmsterdam Pharma, Centessa Pharmaceuticals, Sutro Biopharma, and Opthea. Zealand Pharma AS, a biotechnology company, engages in the discovery, development, and commercialization of peptide-base... More
Zealand Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zealand Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zealand Pharma AS upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 16.31 | |||
| Value At Risk | (5.30) | |||
| Potential Upside | 4.14 |
Zealand Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zealand Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zealand Pharma's standard deviation. In reality, there are many statistical measures that can use Zealand Pharma historical prices to predict the future Zealand Pharma's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (8.08) |
Zealand Pharma AS Backtested Returns
Zealand Pharma AS shows Sharpe Ratio of -0.0821, which attests that the company had a -0.0821% return per unit of risk over the last 3 months. Zealand Pharma AS exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zealand Pharma's Standard Deviation of 3.03, market risk adjusted performance of (8.07), and Mean Deviation of 2.24 to validate the risk estimate we provide. The firm maintains a market beta of 0.038, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zealand Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zealand Pharma is expected to be smaller as well. At this point, Zealand Pharma AS has a negative expected return of -0.25%. Please make sure to check out Zealand Pharma's skewness, and the relationship between the total risk alpha and day median price , to decide if Zealand Pharma AS performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.47 |
Modest reverse predictability
Zealand Pharma AS has modest reverse predictability. Overlapping area represents the amount of predictability between Zealand Pharma time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zealand Pharma AS price movement. The serial correlation of -0.47 indicates that about 47.0% of current Zealand Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 102.31 |
Zealand Pharma AS lagged returns against current returns
Autocorrelation, which is Zealand Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Zealand Pharma's pink sheet expected returns. We can calculate the autocorrelation of Zealand Pharma returns to help us make a trade decision. For example, suppose you find that Zealand Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Zealand Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Zealand Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Zealand Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Zealand Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Zealand Pharma Lagged Returns
When evaluating Zealand Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Zealand Pharma pink sheet have on its future price. Zealand Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Zealand Pharma autocorrelation shows the relationship between Zealand Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Zealand Pharma AS.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Zealand Pink Sheet
Zealand Pharma financial ratios help investors to determine whether Zealand Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.